IP Library Assignment 034767/0324
Patent Assignment
Reel/Frame 034767/0324

Change of Name

Recorded: 2015-01-15 Pages: 11
Assignor
SILENCE THERAPEUTICS AG
Executed: 2014-12-22
Assignee
SILENCE THERAPEUTICS GMBH
ROBERT-ROESSLE-STR 10, BERLIN, 13125, GERMANY
Covered Properties (20)
Interfering Rna Molecules
Patent: 7,452,987 →
Application: 10/633,630 →
Publication: US 2004/0180351
Further Use of Protein Kinase N Beta
Patent: 7,713,943 →
Application: 10/640,274 →
Publication: US 2004/0106569
Lipids, Lipid Complexes and Use Thereof
Patent: 8,017,804 →
Application: 11/579,700 →
Publication: US 2008/0274116
Coated Lipid Complexes and Their Use
Patent: 8,852,472 →
Application: 11/722,948 →
Publication: US 2010/0062967
Interfering Rna Molecules
Patent: 7,893,245 →
Application: 12/200,296 →
Publication: US 2009/0186845
Lipoplex Formulations for Specific Delivery to Vascular Endothelium
Application: 12/297,611 →
Publication: US 2009/0074852
Means for Inhibiting the Expression of Protein Kinase 3
Patent: 8,232,256 →
Application: 12/307,052 →
Publication: US 2009/0304678
Interfering Rna Molecules
Patent: 8,324,370 →
Application: 12/986,389 →
Publication: US 2011/0118456
Means for Inhibiting the Expression of Orc-1
Patent: 8,722,875 →
Application: 13/120,430 →
Publication: US 2011/0217367
Means for Inhibiting the Expression of ANG2
Patent: 8,829,179 →
Application: 13/201,917 →
Publication: US 2012/0022138
Lipids, Lipid Complexes and Use Thereof
Patent: 8,357,722 →
Application: 13/230,085 →
Publication: US 2012/0065138
Further Use of Protein Kinase N Beta
Patent: 9,078,855 →
Application: 13/369,743 →
Publication: US 2012/0171220
Interfering Rna Molecules
Patent: 8,933,215 →
Application: 13/692,178 →
Publication: US 2013/0102769
Lipids, Lipid Complexes and Use Thereof
Patent: 8,735,453 →
Application: 13/742,700 →
Publication: US 2013/0165381
Use of VEGFR1 as a Biomarker
Patent: 9,133,515 →
Application: 13/894,650 →
Publication: US 2014/0179755
Means for Inhibiting the Expression of Orc-1
Application: 14/274,991 →
Publication: US 2014/0249207
Lipids, Lipid Complexes and Use Thereof
Patent: 9,125,820 →
Application: 14/286,033 →
Publication: US 2014/0329885
Means for Inhibiting the Expression of ANG2
Patent: 9,458,461 →
Application: 14/289,916 →
Publication: US 2014/0328903
Coated Lipid Complexes and Their Use
Patent: 9,387,262 →
Application: 14/507,045 →
Publication: US 2015/0031752
Interfering Rna Molecules
Patent: 9,222,092 →
Application: 14/578,636 →
Publication: US 2015/0105545
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 20, 2004
From: KLIPPEL-GIESE, ANKE; KAUFMANN, JOERG
To: ATUGEN AG
Reel/Frame 014905/0222 →
Assignment of Assignor's Interest Feb 4, 2004
From: GIESE, KLAUS; KAUFMANN, JOERG; KLIPPEL-GIESE, ANKE
To: ATUGEN AG
Reel/Frame 014958/0009 →
Assignment of Assignor's Interest Jan 11, 2008
From: KEIL, OLIVER; KAUFMAN, JORG
To: SILENCE THERAPEUTICS AG
Reel/Frame 020354/0560 →
Change of Name Mar 26, 2008
From: ATUGEN AG (AKTIENGESELLSCHAFT)
To: SILENCE THERAPEUTICS AKTIENGESELLSCHAFT (AG)
Reel/Frame 020700/0750 →
Change of Name May 22, 2008
From: ATUGEN AG (AKTIENGESELLSCHAFT)
To: SILENCE THERAPEUTICS AKTIENSELLSCHAFT (AG)
Reel/Frame 020984/0538 →
Assignment of Assignor's Interest May 23, 2008
From: KEIL, OLIVER; KAUFMANN, JORG
To: SILENCE THERAPEUTICS AG
Reel/Frame 020990/0018 →
Assignment of Assignor's Interest Dec 4, 2008
From: KAUFMANN, JORG; KEIL, OLIVER; SANTEL, ANSGAR
To: SILENCE THERAPEUTICS AG
Reel/Frame 021945/0009 →
Assignment of Assignor's Interest Feb 11, 2009
From: GIESE, KLAUS; KAUFMANN, JORG; KLIPPEL-GIESE, ANKE
To: ATUGEN AG
Reel/Frame 022238/0763 →
Change of Name Feb 12, 2009
From: ATUGEN AG (AKTIENGESELLSCHAFT)
To: SILENCE THERAPEUTICS AKTIENGESELLSCHAFT (AG)
Reel/Frame 022249/0052 →
Assignment of Assignor's Interest Apr 10, 2009
From: KAUFMANN, JORG; KEIL, OLIVER; SANTEL, ANSGAR
To: SILENCE THERAPEUTICS AG
Reel/Frame 022532/0224 →
Assignment of Assignor's Interest Apr 5, 2011
From: GOSSEN, MANFRED; SANTEL, ANSGAR; KAUFMANN, JORG
To: SILENCE THERAPEUTICS AG
Reel/Frame 026076/0208 →
Assignment of Assignor's Interest Oct 8, 2011
From: SANTEL, ANSGAR; KAUFMANN, JORG; WITZENRATH, MARTIN
To: SILENCE THERAPEUTICS AG
Reel/Frame 027035/0150 →
Assignment of Assignor's Interest Nov 22, 2011
From: KEIL, OLIVER; KAUFMANN, JORG; SANTEL, ANSGAR
To: SILENCE THERAPEUTICS AG
Reel/Frame 027270/0750 →
Assignment of Assignor's Interest Jan 22, 2013
From: KEIL, OLIVER; KAUFMANN, JORG; SANTEL, ANSGAR
To: SILENCE THERAPEUTICS AG
Reel/Frame 029666/0189 →
Assignment of Assignor's Interest Jul 3, 2013
From: GIESE, KLAUS; KAUFMANN, JOERG
To: SILENCE THERAPEUTICS AG
Reel/Frame 030735/0293 →
Assignment of Assignor's Interest May 14, 2014
From: GOSSEN, MANFRED; SANTEL, ANSGAR; KAUFMANN, JORG
To: SILENCE THERAPEUTICS AG
Reel/Frame 032887/0770 →
Assignment of Assignor's Interest May 28, 2014
From: KEIL, OLIVER; KAUFMANN, JORG; SANTEL, ANSGAR
To: SILENCE THERAPEUTICS AG
Reel/Frame 032971/0931 →
Assignment of Assignor's Interest Aug 4, 2014
From: SANTEL, ANSGAR; KAUFMANN, JORG; WITZENRATH, MARTIN
To: SILENCE THERAPEUTICS AG
Reel/Frame 033464/0730 →